These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20501482)

  • 21. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.
    Becker M; Kramann R; Franke A; Breithardt OA; Heussen N; Knackstedt C; Stellbrink C; Schauerte P; Kelm M; Hoffmann R
    Eur Heart J; 2007 May; 28(10):1211-20. PubMed ID: 17426079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
    Wang CL; Powell BD; Redfield MM; Miyazaki C; Fine NM; Olson LJ; Cha YM; Espinosa RE; Hayes DL; Hodge DO; Lin G; Friedman PA; Oh JK
    Eur J Heart Fail; 2012 May; 14(5):517-25. PubMed ID: 22411692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure.
    Yu CM; Lin H; Fung WH; Zhang Q; Kong SL; Sanderson JE
    Am Heart J; 2003 May; 145(5):E18. PubMed ID: 12766742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.
    Bertini M; Delgado V; Nucifora G; Marsan NA; Ng AC; Shanks M; Van Bommel RJ; Borleffs CJ; Ewe SH; Boriani G; Biffi M; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Sep; 106(5):682-7. PubMed ID: 20723646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure.
    Francia P; Balla C; Ricotta A; Uccellini A; Frattari A; Modestino A; Borro M; Simmaco M; Salvati A; De Biase L; Volpe M
    Int J Cardiol; 2011 Dec; 153(3):306-10. PubMed ID: 20863582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).
    Stockburger M; Gómez-Doblas JJ; Lamas G; Alzueta J; Fernández-Lozano I; Cobo E; Wiegand U; Concha JF; Navarro X; Navarro-López F; de Teresa E
    Eur J Heart Fail; 2011 Jun; 13(6):633-41. PubMed ID: 21613427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of functional mitral regurgitation improvement during a short-term follow-up after cardiac resynchronisation therapy.
    Brzezińska B; Łoboz-Grudzień K; Wita K; Mizia-Stec K; Gąsior Z; Kasprzak JD; Kukulski T; Wojciechowska C; Sinkiewicz W; Kowalik I; Dudek K; Płońska-Gościniak E
    Kardiol Pol; 2016; 74(7):665-73. PubMed ID: 26779854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course of secondary mitral regurgitation in patients with heart failure receiving cardiac resynchronization therapy: Impact on long-term outcome beyond left ventricular reverse remodelling.
    Binda C; Menet A; Appert L; Ennezat PV; Delelis F; Castel AL; Le Goffic C; Guyomar Y; Ringlé A; Guerbaai RA; Graux P; Tribouilloy C; Maréchaux S
    Arch Cardiovasc Dis; 2018 May; 111(5):320-331. PubMed ID: 29102366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy.
    Macioce R; Cappelli F; Demarchi G; Lilli A; Ricciardi G; Pieragnoli P; Colella A; Michelucci A; Porciani MC; Padeletti L
    Minerva Cardioangiol; 2005 Aug; 53(4):329-33. PubMed ID: 16177677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Geleijnse ML; Theuns DA; Nemes A; Vletter WB; van Dalen BM; Motawea AK; Jordaens LJ; ten Cate FJ
    Am J Cardiol; 2008 Mar; 101(5):651-7. PubMed ID: 18308015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization.
    Becker M; Hoffmann R; Schmitz F; Hundemer A; Kühl H; Schauerte P; Kelm M; Franke A
    Am J Cardiol; 2007 Dec; 100(11):1671-6. PubMed ID: 18036367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse remodelling induces progressive ventricular resynchronization after cardiac resynchronization therapy 'from vicious to virtuous cycle'.
    Matsumoto K; Tanaka H; Okajima K; Hayashi T; Kajiya T; Sugiyama D; Kawai H; Hirata K
    Eur J Echocardiogr; 2011 Oct; 12(10):782-9. PubMed ID: 21865225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty for intermediate-degree ischemic mitral regurgitation.
    Pocar M; Passolunghi D; Moneta A; Di Mauro A; Bregasi A; Mattioli R; Donatelli F
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1529-38. PubMed ID: 19969313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy.
    Verhaert D; Popović ZB; De S; Puntawangkoon C; Wolski K; Wilkoff BL; Starling RC; Tang WH; Thomas JD; Griffin BP; Grimm RA
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):21-6. PubMed ID: 22047983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.